Patent ID: 8632991

Claim:
A method of enhancing blood coagulation in a subject, the method comprising (i) administering to the subject diagnosed as having a blood coagulation disorder a procoagulant amount of a composition comprising a purified non-anticoagulant sulfated polysaccharide (NASP) comprising 70% or more fucose saccharide residues; the NASP having fucoidan selected from the group consisting of Fucoidan 5307002, Fucus vesiculosus , max. MW peak 126.7 kD; Fucoidan VG49, Fucus vesiculosus , hydrolyzed sample of 5307002 of lower MW, max. MW peak 22.5 kD; Fucoidan VG57, Undaria pinnatifida , high charge high sulphation, deacetylated; Fucoidan 5508005, Undaria pinnatifida , depyrogenated; Fucoidan L/FVF-01091, Fucus vesiculosus , depyrogenated, max. MW peak 125 kD; Fucoidan L/FVF-01092, Fucus vesiculosus , depyrogenated, max. MW peak 260 kD; Fucoidan L/FVF-01093, Fucus vesiculosus , hydrolyzed depyrogenated, max. MW peak 36 kD; fucoidan from Ecklonia radiata ; fucoidan from Ecklonia maxima ; fucoidan from Macrocystis pyrifera ; and combinations thereof; wherein the procoagulant amount is an effective amount of the composition to enhance blood coagulation in the subject.